Role of IL28B polymorphism in the development of hepatitis C virus-induced hepatocellular carcinoma, graft fibrosis, and posttransplant antiviral therapy

Transplantation

Volumn 93, Issue 6, 2012, Pages 644-649

  Eurich, Dennis ^a,b   Boas Knoop, Sabine ^c   Bahra, Marcus ^c   Neuhaus, Ruth ^c   Somasundaram, Rajan ^c   Neuhaus, Peter ^c   Neumann, Ulf ^c   Seehofer, Daniel ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c University Aachen ^*

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; ALPHA INTERFERON; AMANTADINE; BASILIXIMAB; BETA INTERFERON; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN A; INTERFERON; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN; SILIBININ; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ALLELE; ANTIVIRAL THERAPY; ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; EXPLANT; FEMALE; GENE; GENETIC POLYMORPHISM; GENOTYPE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IL28B GENE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; PREOPERATIVE PERIOD; PRIORITY JOURNAL;

ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FIBROSIS; GENOTYPE; GRAFT REJECTION; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERLEUKINS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POLYMORPHISM, GENETIC; PREVALENCE; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 84858684409     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318244f774     Document Type: Article

References (0)